Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Levin

Showing results (641-650 of 723) with videos related to

Pageof 73
Sort By:
Mbio|February 18, 2026
Differential targeting of human pyroptotic caspase-5 and caspase-4 by <i>Shigella</i> OspC2 and OspC3Kyungsub Kim, Marcos Antonio Valdespino Diaz, Rowan M Karr, et al.
Glia|May 3, 2023
Acute intermittent hypoxia alters disease course and promotes CNS repair including resolution of inflammation and remyelination in the experimental autoimmune encephalomyelitis model of MSNataliya Tokarska, Justin M A Naniong, Jayne M Johnston, et al.
Aging|February 1, 2012
Deficiency of the lipid synthesis enzyme, DGAT1, extends longevity in miceRyan S Streeper, Carrie A Grueter, Nathan Salomonis, et al.
Clinical Chemistry|October 26, 2005
Characterization of publicly available lymphoblastoid cell lines for disease-associated mutations in 11 genesSusan H Bernacki, Jeanne C Beck, Kasinathan Muralidharan, et al.
Nature Medicine|May 2, 2002
Autoimmunity due to molecular mimicry as a cause of neurological diseaseMichael C Levin, Sang Min Lee, Franck Kalume, et al.
American Journal of Physiology. Endocrinology and Metabolism|October 18, 2007
Increased lipid accumulation and insulin resistance in transgenic mice expressing DGAT2 in glycolytic (type II) muscleMalin C Levin, Mara Monetti, Matthew J Watt, et al.
Cardiovascular Research|July 2, 2015
Rip2 modifies VEGF-induced signalling and vascular permeability in myocardial ischaemiaLinda Andersson, Margareta Scharin Täng, Annika Lundqvist, et al.
Social Science & Medicine (1982)|November 15, 2018
How can we evaluate the cost-effectiveness of health system strengthening? A typology and illustrationsK Hauck, A Morton, K Chalkidou, et al.
The Journal of Infectious Diseases|August 7, 1999
HTLV-I/II seroindeterminate Western blot reactivity in a cohort of patients with neurological diseaseS S Soldan, M D Graf, A Waziri, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|July 14, 2020
Treatment Optimization in Multiple Sclerosis: Canadian MS Working Group RecommendationsMark S Freedman, Virginia Devonshire, Pierre Duquette, et al.
Pageof 73

Showing results (641-650 of 723) with videos related to

Sort By:
Pageof 73
Mbio|February 18, 2026
Differential targeting of human pyroptotic caspase-5 and caspase-4 by <i>Shigella</i> OspC2 and OspC3Kyungsub Kim, Marcos Antonio Valdespino Diaz, Rowan M Karr, et al.
Glia|May 3, 2023
Acute intermittent hypoxia alters disease course and promotes CNS repair including resolution of inflammation and remyelination in the experimental autoimmune encephalomyelitis model of MSNataliya Tokarska, Justin M A Naniong, Jayne M Johnston, et al.
Aging|February 1, 2012
Deficiency of the lipid synthesis enzyme, DGAT1, extends longevity in miceRyan S Streeper, Carrie A Grueter, Nathan Salomonis, et al.
Clinical Chemistry|October 26, 2005
Characterization of publicly available lymphoblastoid cell lines for disease-associated mutations in 11 genesSusan H Bernacki, Jeanne C Beck, Kasinathan Muralidharan, et al.
Nature Medicine|May 2, 2002
Autoimmunity due to molecular mimicry as a cause of neurological diseaseMichael C Levin, Sang Min Lee, Franck Kalume, et al.
American Journal of Physiology. Endocrinology and Metabolism|October 18, 2007
Increased lipid accumulation and insulin resistance in transgenic mice expressing DGAT2 in glycolytic (type II) muscleMalin C Levin, Mara Monetti, Matthew J Watt, et al.
Cardiovascular Research|July 2, 2015
Rip2 modifies VEGF-induced signalling and vascular permeability in myocardial ischaemiaLinda Andersson, Margareta Scharin Täng, Annika Lundqvist, et al.
Social Science & Medicine (1982)|November 15, 2018
How can we evaluate the cost-effectiveness of health system strengthening? A typology and illustrationsK Hauck, A Morton, K Chalkidou, et al.
The Journal of Infectious Diseases|August 7, 1999
HTLV-I/II seroindeterminate Western blot reactivity in a cohort of patients with neurological diseaseS S Soldan, M D Graf, A Waziri, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|July 14, 2020
Treatment Optimization in Multiple Sclerosis: Canadian MS Working Group RecommendationsMark S Freedman, Virginia Devonshire, Pierre Duquette, et al.
Pageof 73